Skip to main content
. 2017 Nov 13;7:15428. doi: 10.1038/s41598-017-15832-5

Figure 1.

Figure 1

5-HT, 5-Htr1a specific agonist and 5-Htr1b specific agonist inhibit prostate branching morphogenesis. (a) Photographs of representative VPs at D0 and at D4 of culture treated with different 5-HT concentrations. (b) Morphometric analysis of the effect of 5-HT on VPs area and (c) number of peripheral buds (n ≥ 12 VPs per group). (d) Immunofluorescence analysis of 5-Htr1a and (e) 5-Htr1b expression in the rat prostate. (f) Photographs of representative VPs at D0 and at D4 of culture treated with different 8-OH-DPAT concentrations. (g) Morphometric analysis of the effect of 8-OH-DPAT on VPs area and (h) number of peripheral buds (n ≥ 12 VPs per group). (i) Photographs of representative VPs at D0 and at D4 of culture treated with different anpirtoline concentrations. (j) Morphometric analysis of the effect of Anpirtoline on VPs area and (k) number of peripheral buds (n ≥ 12 VPs per group). Error bars indicate s.e.m. ***p < 0.001; two-way ANOVA and Bonferroni post hoc test. VPs, ventral prostate explants; D0, day 0; D4, day 4; 5-HT, serotonin.